BAG-1, an anti-apoptotic tumour marker

IUBMB Life

Volumn 53, Issue 2, 2002, Pages 99-105

  Tang, Shou Ching ^a  

^a MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

Author keywords

Apoptosis; BAG 1; Breast cancer; Laryngeal cancer; Lung cancer; Oral cancer; Prognosis and biomarker; Review

Indexed keywords

BAG 1 PROTEIN; HEAT SHOCK PROTEIN; PROTEIN BCL 2; TUMOR MARKER; UNCLASSIFIED DRUG; BCL2 ASSOCIATED ATHANOGENE 1 PROTEIN; BCL2-ASSOCIATED ATHANOGENE 1 PROTEIN; CARRIER PROTEIN; DNA BINDING PROTEIN; ISOPROTEIN; STEROID RECEPTOR; TRANSCRIPTION FACTOR;

APOPTOSIS; BREAST CANCER; CELLULAR DISTRIBUTION; DISEASE MARKER; HUMAN; LARYNX CANCER; LUNG CANCER; MOUTH CANCER; NONHUMAN; PROGNOSIS; PROTEIN EXPRESSION; REVIEW; METABOLISM; NEOPLASM;

APOPTOSIS; CARRIER PROTEINS; HEAT-SHOCK PROTEINS; HUMAN; NEOPLASMS; PROGNOSIS; PROTEIN ISOFORMS; RECEPTORS, STEROID; TUMOR MARKERS, BIOLOGICAL; DNA-BINDING PROTEINS; HUMANS; TRANSCRIPTION FACTORS;

EID: 0036001160     PISSN: 15216543     EISSN: None     Source Type: Journal    
DOI: 10.1080/15216540211473     Document Type: Review

References (65)

1. Cloning and functional analysis of BAG-1: A novel Bcl-2 binding protein with anti-cell death activity
2. Bcl-2 interacting protein, BAG-1, binds to and activates the kinase Raf-1
3. HGF receptor associates with the anti-apoptotic protein BAG-1 and prevents cell death
4. Role of BAG-1 in the survival and proliferation of the cytokine-dependent lymphocyte lines, Ba/F3 and Nb2
5. Anti-apoptotic genes, bag-1 and Bcl-2, enabled hybridoma cells to survive under treatment for arresting cell cycle
6. Prolonged cell survival enhances peritoneal dissemination of gastric cancer cells
7. Anti-cell death activity promotes pulmonary metastasis of melanoma cells
8. BAG-1 expression correlates highly with the malignant potential in early lesions (T1 and T2) of oral squamous cell carcinoma
9. A protein that interacts with members of the nuclear hormone receptor family: Identification and cDNA cloning
10. RAP46 is a negative regulator of glucocorticoid receptor action and hormone-induced apoptosis
11. BAG-1L protein enhances androgen receptor function
12. BAG-1 p50 isoform interacts with the vitamin D receptor and its cellular overexpression inhibits the vitamin D pathway
13. Interaction of BAG-1 with retinoic acid receptor and its inhibition of retinoic acid-induced apoptosis in cancer cells
14. Heat shock factor function and regulation in response to cellular stress, growth, and differentiation signals
15. Heat shock proteins: Endogenous modulators of apoptotic cell death
16. Stress management - Heat shock protein-70 and the regulation of apoptosis
17. Hsp70 interactions with the p53 tumour suppressor protein
18. Role of the heat shock response and molecular chaperones in oncogenesis and cell death
19. Mammalian protein RAP46: An interaction partner and modulator of 70 kDa heat shock proteins
20. GrpE-like regulation of the Hsc70 chaperone by the anti-apoptotic protein BAG-1
21. The ubiquitin-related BAG-1 provides a link between the molecular chaperones Hsc70/Hsp70 and the proteasome
22. Modulation of in vivo HSP70 chaperone activity by Hip and Bag-1
23. An evolutionarily conserved family of Hsp70/Hsc70 molecular chaperone regulators
24. Structure of a Bag/Hsc70 complex: Convergent functional evolution of Hsp70 nucleotide exchange factors
25. Isolation of Bcl-2 binding proteins that exhibit homology with BAG-1 and suppressor of death domains protein
26. Cooperative interception of neuronal apoptosis by Bcl-2 and BAG-1 expression: Prevention of caspase activation and reduced production of reactive oxygen species
27. Resistance to apoptosis is correlated with the reduced caspase-3 activation and enhanced expression of anti-apoptotic proteins in human cervical multidrug-resistant cells
28. Human papillomavirus type 16-immortalized endocervical cells selected for resistance to cisplatin are malignantly transformed and have a multidrug resistance phenotype
29. Cloning and characterization of the human BAG-1 gene promoter: Upregulation by tumor-derived p53 mutants
30. BAG-1 and Bcl-2 in IL-2 signaling
31. Fas ligand gene transfer prolongs rat renal allograft survival and down-regulates anti-apoptotic Bag-1 in parallel with enhanced Th2-type cytokine expression
32. The hsp70-associating protein Hap46 binds to DNA and stimulates transcription
33. Transcriptional activation by the human Hsp70-associating protein Hap50
34. BAG-1M, an isoform of Bcl-2-interacting protein BAG-1, enhances gene expression driven by CMV promoter
35. BAG-1, a novel Bcl-2-interacting protein, activates expression of human JC virus
36. Mammallian cells express two differently localized Bag-1 isoforms generated by alternative translation initiation
37. Human BAG-1/RAP 46 is generated as four isoforms by alternative translation initiation and overexpressed in cancer cells
38. Enhanced expression of anti-apoptotic proteins in human papillomavirus-immortalized and cigarette smoke condensate-transformed human endocervical cells: Correlation with resistance to apoptosis induced by DNA damage
39. High level expression of differentially localized BAG-1 isoforms in some oestrogen receptor-positive human breast cancers
40. Distinct isoforms of the cofactor BAG-1 differentially affect Hsc70 chaperone function
41. Isoform-specific expression of BAG-1 in mouse development
42. P53, apoptosis and breast cancer
43. p53 and chemosensitivity
44. Predicting the biologic behavior of ductal carcinoma in situ: An analysis of molecular markers
45. The role of bcl-2 expression in breast carcinomas
46. Clinical studies of Bcl-2 and treatment benefit in breast cancer patients
47. A pitfall in the survival benefit of adjuvant chemotherapy for node- and hormone receptor-positive patients with breast cancer: The paradoxical role of Bcl-2 oncoprotein
48. Novel compounds in the therapy of breast cancer: Opportunities for integration with docetaxel
49. The contribution of molecular markers to the prediction of response in the treatment of breast cancer: A review of the literature on HER-2, p53 and BCL-2
50. Clinical significance of Bcl-2-MBR gene rearrangement and protein expression in diffuse large-cell non-Hodgkin's lymphoma: An analysis of 83 cases
51. Differential expression of anti-apoptotic gene BAG-1 in human breast normal and cancer cell lines and tissues
52. Expression of multiple apoptosis-regulatory genes in human breast cancer cell lines and primary tumors
53. Expression of BAG-1 in invasive breast carcinoma
54. BAG-1: A novel biomarker predicting long-term survival in early-stage breast cancer
55. Prognostic significance of apoptosis regulators in breast cancer
56. Bcl-2 protein and prognosis in patients with potentially curable non-small cell lung cancer
57. Bcl-2 expression in non-small cell lung cancer: Higher frequency of expression in squamous cell carcinomas with earlier pT status
58. Clinical significance of p53 in non-small-cell lung cancer
59. Prognostic significance of p53 alterations in patients with non-small cell lung cancer: A meta-analysis
60. Retinoic acid-mediated G1 arrest is associated with induction of p27(Kip1) and inhibition of cyclin-dependent kinase 3 in human lung squamous carcinoma CH27 cells
61. Retinoic acid receptor and retinoid X receptor alterations in lung cancer precursor lesions
62. Evidence that retinoic acid receptor beta induction by retinoids is important for tumor cell growth inhibition
63. Prognostic significance of BAG-1 expression in non-small cell lung cancer
64. Nuclear BAG-1 localization and the risk of recurrence after radiation therapy in laryngeal carcinomas
65. Expression of apoptosis-regulating proteins in chronic lymphocytic leukemia: Correlation with in vitro and in vivo chemoresponses